Michael Batalia
Direktor/Vorstandsmitglied bei Kucera Pharmaceutical Co.
Profil
Michael Batalia is currently the Director at Wake Forest School of Medicine and the Director at Kucera Pharmaceutical Co. He is also the Principal at Wake Forest University.
In the past, he worked as the Associate Director at North Carolina State University and as the Vice President-Eastern Region at The Association of University Technology Managers, Inc. He was also a Member at The University of North Carolina at Charlotte.
Dr. Batalia holds a doctorate degree from The University of Texas at Austin and an undergraduate degree from The University of Chicago.
Aktive Positionen von Michael Batalia
| Unternehmen | Position | Beginn |
|---|---|---|
Kucera Pharmaceutical Co.
 Kucera Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Kucera is developing a pipeline of drugs that have improved efficacy and potentially improved toxicity profiles by taking advantage of the unique biological and chemical properties of its proprietary small molecule platform. Kucera has small molecules which act alone as therapeutic agents. Kucera's unique proprietary molecules can also be chemically conjugated to other small molecule drugs creating a series of carrier prodrugs. Both the prodrugs and small molecules will be classified as new chemical entities (NCEs) and will benefit from a new or an extended patent on the existing small molecule. Kucera's headquarters is in the Piedmont Triad Research Park, Winston-Salem, N.C. Kucera Pharmaceutical Co. The company was founded on June 14, 2001 and is headquartered in Winston Salem, NC. | Direktor/Vorstandsmitglied | - |
| Wake Forest University | Corporate Officer/Principal | 25.02.2010 |
| Wake Forest School of Medicine | Direktor/Vorstandsmitglied | 02.08.2011 |
Ehemalige bekannte Positionen von Michael Batalia
| Unternehmen | Position | Ende |
|---|---|---|
The Association of University Technology Managers, Inc.
 The Association of University Technology Managers, Inc. Miscellaneous Commercial ServicesCommercial Services The Association of University Technology Managers engages in gathering and reporting detailed information about technology transfer. The firm also provides research reports, databases, learning center, and global technology portal and technology transfer practice manual. The company was founded by Larry Gilbert in 1974 and is headquartered in Oakbrook, IL. | Corporate Officer/Principal | - |
| The University of North Carolina at Charlotte | Corporate Officer/Principal | - |
| North Carolina State University | Corporate Officer/Principal | - |
Ausbildung von Michael Batalia
| The University of Texas at Austin | Doctorate Degree |
| The University of Chicago | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
The Association of University Technology Managers, Inc.
The Association of University Technology Managers, Inc. Miscellaneous Commercial ServicesCommercial Services The Association of University Technology Managers engages in gathering and reporting detailed information about technology transfer. The firm also provides research reports, databases, learning center, and global technology portal and technology transfer practice manual. The company was founded by Larry Gilbert in 1974 and is headquartered in Oakbrook, IL. | Commercial Services |
Kucera Pharmaceutical Co.
Kucera Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Kucera is developing a pipeline of drugs that have improved efficacy and potentially improved toxicity profiles by taking advantage of the unique biological and chemical properties of its proprietary small molecule platform. Kucera has small molecules which act alone as therapeutic agents. Kucera's unique proprietary molecules can also be chemically conjugated to other small molecule drugs creating a series of carrier prodrugs. Both the prodrugs and small molecules will be classified as new chemical entities (NCEs) and will benefit from a new or an extended patent on the existing small molecule. Kucera's headquarters is in the Piedmont Triad Research Park, Winston-Salem, N.C. Kucera Pharmaceutical Co. The company was founded on June 14, 2001 and is headquartered in Winston Salem, NC. | Health Technology |
